- Home
- Products
Ninlaro (Ixazomib)
Ninlaro (Ixazomib)
- Medicine Name: Ninlaro
- Generic Name: Ixazomib
- Dosage Form & Strength: Capsules – 2.3 mg, 3 mg, 4 mg
- Manufactured By: Takeda Pharmaceuticals Inc
Ninlaro is a proteasome inhibitor used as part of a combination therapy with lenalidomide and dexamethasone for treating adults diagnosed with multiple myeloma who have undergone at least one prior treatment.
Recommended Dosage:
- Ninlaro: 4 mg orally once a week on Days 1, 8, and 15 of a 28-day cycle
- Lenalidomide: 25 mg daily on Days 1 to 21 of each cycle
- Dexamethasone: 40 mg on Days 1, 8, 15, and 22
Ninlaro should be taken either 1 hour before or 2 hours after food. The capsule must be swallowed whole with water, without crushing or chewing. If vomiting occurs after taking the capsule, the dose should not be repeated.
Platelet Monitoring: Thrombocytopenia is a common side effect. Platelet counts should be checked monthly, with more frequent testing during the initial three treatment cycles.
Thrombotic Microangiopathy: Serious conditions like HUS/TTP may develop. Discontinue if diagnosed.
Liver Toxicity: Monitor liver function closely. Dose modification may be necessary for hepatic side effects.
Pregnancy Risk: Ninlaro can cause fetal harm. Avoid use during pregnancy. Male patients should use effective contraception during treatment and for 90 days afterward.
Required Documents to Import Ninlaro to India:
- Valid prescription from a licensed doctor
- Diagnostic reports supporting the treatment
- Government-issued ID proof of the patient
Availability in India:
Ninlaro (Ixazomib) is a prescription medicine that can be imported into India through named-patient programs for personal use by patients or government hospitals.
Service Offered by Global Rare Meds:
- Verification of prescription and documentation
- Access to genuine supply from authorized sources in the USA, Canada, Europe, and Australia
- Delivery support to cities like Mumbai, Delhi, Bengaluru, Chennai, Kolkata, Pune, Ahmedabad, and more
Orders are confirmed only after submitting a valid prescription and, if applicable, an import permit.
For assistance, contact:
📧 info@globalraremeds.com
📞 +91-99675 15602 (Call/WhatsApp)
Global Rare Meds sources Ninlaro from globally authorized suppliers and ensures medicines are dispensed under strict regulatory compliance. All orders are fulfilled from our licensed Fulfillment Center in Ambernath, Thane District, and delivered directly to the patient’s address.
Our team ensures quality, timely delivery, and full legal adherence to named-patient import regulations in India and internationally.
Q: What is the generic name of Ninlaro®?
A: The generic name is Ixazomib.
Q: Who manufactures Ninlaro®?
A: Takeda Pharmaceuticals Inc.
Q: Is Ninlaro® approved by the FDA?
A: Yes, it was approved by the FDA on November 20, 2015.
Q: What dosage forms are available for Ninlaro®?
A: Capsules in 2.3 mg, 3 mg, and 4 mg strengths for oral administration.
Q: What are the common side effects?
A: Common adverse effects include diarrhea, constipation, nausea, vomiting, peripheral neuropathy, thrombocytopenia, neutropenia, rash, and peripheral edema.
Q: How should Ninlaro® be stored?
A: Store at room temperature (below 30°C). Do not freeze. Keep the capsules in original packaging until use.
Q: How can I get Ninlaro® in India at the best price?
A: For pricing and procurement support, contact Global Rare Meds at +91-99675 15602 or email info@globalraremeds.com.
Q: Can Ninlaro® be legally imported into India?
A: Yes, under a valid prescription and as per applicable import guidelines, Global Rare Meds can assist with the legal importation of Ninlaro for personal use.
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
